Pharma eyes AI deals to stem lost revenues from patent expirations
Pharmaceutical giants are employing an array of tactics to minimise the falling revenues that come when patents expire on their top drugs. Among these, experts say artificial intelligence (AI) is playing a growing and potentially revolutionary role. A wave …